|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 1.470 USD | -1.34% |
|
-6.96% | -20.97% |
| 09-17 | Lisata Therapeutics, Inc.(NasdaqCM:LSTA) added to NASDAQ Composite Index | CI |
| 09-17 | Lisata Therapeutics, Inc. (Nasdaq: LSTA) acquired Marea Therapeutics, Inc. for approximately $240 million. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 13.25M | - | - | - | - | - |
| 74.16B | |||||
| 57.39B | |||||
| 47.64B | |||||
| 44.29B | - | - | - | - | - |
| 42.5B |
Select your edition
All financial news and data tailored to specific country editions
